Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial

Journal of Cellular Biochemistry

Volumn 76, Issue 2, 2000, Pages 311-321

  Bruno, Silvia ^a,b   Torrisi, Rosalba ^a,c   Costantini, Massimo ^a   Baglietto, Laura ^c   Fontana, Vincenzo ^a   Gatteschi, Beatrice ^a   Melioli, Giovanni ^a   Nicolo, Guido ^a   Curotto, Antonio ^a   Malcangi, Bruno ^d   Bruttini, Gian Paolo ^e   Varaldo, Marco ^d   Bruzzi, Paolo ^a   Decensi, Andrea ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d Ospedale Andrea Gallino   (Italy)

^e Department of General Surgery   (Italy)

Author keywords

Biomarker; Bladder cancer; DNA flow cytometry

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOLOGY; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PLOIDY; PRIORITY JOURNAL;

EID: 17544389525     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000201)76:2<311::AID-JCB14>3.0.CO;2-A     Document Type: Article

References (33)

1. Benson NA, Braylan RC. 1994. Evaluation of sensitivity in DNA aneuploidy detection using a mathematical model. Cytometry 15:53-58.
2. Bittard H, Lamy B, Billery C. 1996. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. J Urol 155:1887-1891.
3. Bretton PR, Herr HW, Kimmel M, Fair WR, Whitmore WF Jr, Melamed MR. 1989. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin. J Urol 141:1332-1336.
4. Cajulis RS, Haines GK 3rd, Frias-Hidvegi D, McVary K, Bacus JW. 1995. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn Cytopathol 13:214-223.
5. Chabanas A, Rambeaud J-J, Seigneurin D, Fradet Y, Lawrence J-J, Faure G. 1993. Flow and image cytometry for DNA analysis in bladder washings: improved concordance by using internal reference for flow. Cytometry 14:943-950.
6. Collste LG, Devonec M, Darzynkiewicz Z, Traganos F, Sharpless TK, Whitmore WF Jr, Melamed MR. 1980. Bladder cancer diagnosis by flow cytometry. Cancer 45: 2389-2394.
7. Decensi A, Bruno S, Giaretti W, Torrisi R, Curotto A, Gatteschi B, Geido E, Polizzi A, Costantini M, Bruzzi P, Nicolò G, Costa A, Boccardo F, Giuliani L, Santi L. 1992. Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint. J Cell Biochem suppl 16i:139-147.
8. Decensi A, Bruno S, Costantini M, Torrisi R, Curotto A, Gatteschi B, Nicolò G, Polizzi A, Perloff M, Malone WF, Bruzzi P. 1994. Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point. J Natl Cancer Inst 86:138-140.
9. Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A. 1996. Effect of Tamoxifen on endometrial proliferation. J Clin Oncol 14:434-440.
10. DeVere White RW, Deitch AD, West B, Fitzpatrick JM. 1988. The predictive value of flow cytometric information in the clinical management of stage 0 (Ta) bladder cancer. J Urol 139:279-282.
11. Fleiss JL. 1981. Statistical methods for rates and proportion. 2nd ed. New York: Wiley-Liss.
12. Giella JG, Ring K, Olsson CA, Karp FS, Benson MC. 1992. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. J Urol 148:292-296.
13. Halperin M, Blackwelder WC, Verter J. 1971. Estimation of the multivariate logistic risk function: a comparison of the discriminant function and maximum likelihood approaches. J Chronic Dis 24:125-131.
14. Hijazi A, Devonec M, Bouvier R, Bringuier P, Revillard JP. 1991. Use of leukocytes infiltrating bladder tumors as an internal reference for determining the DNA index by flow cytometry. Anal Quant Cytol Histol 13:139-142.
15. Hong WK, Sporn MB. 1997. Recent advances in chemoprevention of cancer. Science 278:1073-1077.
16. Hopman AHN, Moesker O, Smeets AWGB, Pauwels RPE, Vooijs GP. 1991. Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51:644-651.
17. Kalish LA, Garnick MB, Richie JP. 1987. Appropriate endpoints for superficial bladder cancer clinical trials. J Clin Oncol 5:2004-2008.
18. Klein FA, White FKH. 1988. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience. J Urol 139:275-278.
19. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne FM, Pavone-Macaluso M, Oosterlinck W. 1995. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 31A:1840-1846.
20. Landis SH, Murray T, Bolden S, Wingo PA. 1998. Cancer Statistics. CA Cancer J Clin 48:6-29.
21. Matsuyama H, Bergerheim US, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P. 1994. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77:118-124.
22. Murphy WM. 1990. Current status of urinary cytology in the evaluation of the bladder neoplasm. Hum Pathol 21:886-896.
23. Rabinovitch PS. 1992. Practical considerations for DNA content and cell cycle analysis. In: Bauer KD, Duque RE, Shankey TV, editors. Clinical flow cytometry. Baltimore: Williams and Wilkins. p 117-142.
24. Sauter G, Gasser TC, Moch H, Richter J, Jiang F, Albrecht R, Novotny H, Wagner U, Bubendorf L, Mihatsch MJ. 1997. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res 25 suppl 1:837-43.
25. Shackney SE, Berg G, Simon SR, Cohen J, Amina S, Pommersheim W, Yakulis R, Wang S, Uhl M, Smith CA, Pollice AA, Hartshock RJ. 1995. Origins and implications of aneuploidy in early bladder cancer. Cytometry 22:307-316.
26. Siegel S. 1956. Non-parametric statistics for behavioral science. New York: McGraw-Hill.
27. Sole M, Alos L, Mallofre C, Romero JA, Muntane J, Cardesa A. 1995. Bladder wash flow cytometry in transitional cell carcinoma: useful or misleading? Urol Res 22:361-365.
28. Tetu B, Allard P, Fradet Y, Roberge N, Bernard P. 1996. Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer. Hum Pathol 27:922-926.
29. Vindeløv LL, Christensen IJ, Engelholm SA, Guldhammer BH, Hojgaard K, Sorensen BL, Wolf H. 1995. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas. Cytometry 22:93-102.
30. Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B. 1993. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14: 478-481.
31. Wheeless LL, Coon JS, Cox C, Deitch AD, de Vere White RW, Fradet Y, Koss LG, Melamed MR, O'Connell MJ, Reeder JE, Weinstein RS, Wersto RP. 1991a. Precision of DNA flow cytometry in inter-institutional analyses. Cytometry 12:405-412.
32. Wheeless LL, Reeder JE, O'Connell MJ, Robinson RD, Cosgriff JM, Fradet Y, Frank IN, Cockett ATK. 1991b. DNA Slit-Scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells. Cytometry 12:140-146.
33. Wijkström H, Granberg-Öhman I, Tribukait B. 1984. Chromosomal and DNA patterns in transitional cell bladder carcinoma. Cancer 53:1718-1723.